Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
Cancers · 25.01.2023 · 15 (3) · 753
DOI: 10.3390/cancers15030753 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 25.01.2023. Verfasst von Jia-I Liao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Taipei Veterans General Hospital.
Abstract (Originalsprache)
Patients with hepatocellular carcinoma (HCC) often have co-existing ascites, which is a hallmark of liver decompensation. The albumin-bilirubin (ALBI) grade and EZ (easy)-ALBI grade are used to assess liver functional reserve in HCC, but the predictive accuracy of these two models in HCC patients with ascites is unclear. We aimed to determine the prognostic role of ALBI and EZ-ALBI grades in these patients. A total of 4431 HCC patients were prospectively enrolled and retrospectively analyzed. Independent prognostic predictors were identified by the multivariate Cox proportional hazards model. Of all patients, 995 (22.5%) patients had ascites. Grade 1, 2, and 3 ascites were found in 16%, 4%, and 3% of them, respectively. A higher ascites grade was associated with higher ALBI and EZ-ALBI scores and linked with decreased overall survival. In the Cox multivariate analysis, serum bilirubin level > 1.1 mg/dL, creatinine level ≥ 1.2 mg/dL, α-fetoprotein ≥ 20 ng/mL, total tumor volume > 100 cm3, vascular invasion, distant metastasis, poor performance status, ALBI grade 2 and 3, EZ-ALBI grade 2 and 3, and non-curative treatments were independently associated with increased mortality (all p < 0.05) among HCC patients with ascites. The ALBI and EZ-ALBI grade can adequately stratify overall survival in both the entire cohort and specifically in patients with ascites. Ascites is highly prevalent and independently predict patient survival in HCC. The ALBI and EZ-ALBI grade are feasible markers of liver dysfunction and can stratify long-term survival in HCC patients with ascites.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
- Division of Gastroenterology and Hepatology, Min-Sheng General Hospital, Taoyuan 330, Taiwan.
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Medicine, Renown Regional Medical Center, Reno, NV 89502, USA.
- Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
ORCID-Profile: Yi-Hsiang Huang, Chien-Wei Su, Teh-Ia Huo
Förderung
- NIDDK NIH HHS
- Taipei Veterans General Hospital
Zitieren
APA
Liao, J. I., Ho, S. Y., Liu, P. H., Hsu, C. Y., Huang, Y. H., Su, C. W., Hou, M. C., & Huo, T. I. (2023). Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade. Cancers, 15(3), 753. https://doi.org/10.3390/cancers15030753
Vancouver
Liao JI, Ho SY, Liu PH, Hsu CY, Huang YH, Su CW, et al. Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade. Cancers. 2023;15(3):753. doi:10.3390/cancers15030753
BibTeX
@article{Liao2023,
author = {Liao, Jia-I and Ho, Shu-Yein and Liu, Po-Hong and Hsu, Chia-Yang and Huang, Yi-Hsiang and Su, Chien-Wei and Hou, Ming-Chih and Huo, Teh-Ia},
title = {Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {753},
doi = {10.3390/cancers15030753}
}
EUVIMED